dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - les médicaments utilisés dans le diabète - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 et 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.
ag-dapagliflozin comprimé
angita pharma inc. - dapagliflozine - comprimé - 5mg - dapagliflozine 5mg
ag-dapagliflozin comprimé
angita pharma inc. - dapagliflozine - comprimé - 10mg - dapagliflozine 10mg
apo-dapagliflozin-metformin comprimé
apotex inc - dapagliflozine; chlorhydrate de metformine - comprimé - 5mg; 850mg - dapagliflozine 5mg; chlorhydrate de metformine 850mg
apo-dapagliflozin-metformin comprimé
apotex inc - dapagliflozine; chlorhydrate de metformine - comprimé - 5mg; 1000mg - dapagliflozine 5mg; chlorhydrate de metformine 1000mg
nra-dapagliflozin comprimé
nora pharma inc - dapagliflozine - comprimé - 5mg - dapagliflozine 5mg
nra-dapagliflozin comprimé
nora pharma inc - dapagliflozine - comprimé - 10mg - dapagliflozine 10mg
pro-dapagliflozin comprimé
pro doc limitee - dapagliflozine - comprimé - 5mg - dapagliflozine 5mg
pro-dapagliflozin comprimé
pro doc limitee - dapagliflozine - comprimé - 10mg - dapagliflozine 10mg
apo-dapagliflozin comprimé
apotex inc - dapagliflozine - comprimé - 5mg - dapagliflozine 5mg